356 related articles for article (PubMed ID: 12667176)
21. Olanzapine for treatment-refractory psychosis in patients responsive to, but intolerant of, clozapine.
Weiss EL; Longhurst JG; Bowers MB; Mazure CM
J Clin Psychopharmacol; 1999 Aug; 19(4):378-80. PubMed ID: 10440469
[No Abstract] [Full Text] [Related]
22. Antidepressants in the postpartum period: additional considerations.
Burbeck R; Pilling S; Tomson D; McDonald L
Am J Psychiatry; 2008 Feb; 165(2):262-3; author reply 263. PubMed ID: 18245193
[No Abstract] [Full Text] [Related]
23. [Is bone marrow inhibition a special risk in connection with olanzapine (Zyprexa) treatment?].
Gram LF
Ugeskr Laeger; 2000 Oct; 162(44):5961. PubMed ID: 11094569
[No Abstract] [Full Text] [Related]
24. Effectiveness of olanzapine treatment for severe obsessive-compulsive disorder.
Marazziti D; Pallanti S
Am J Psychiatry; 1999 Nov; 156(11):1834-5. PubMed ID: 10553756
[No Abstract] [Full Text] [Related]
25. Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: an open-label case series.
Weiss EL; Potenza MN; McDougle CJ; Epperson CN
J Clin Psychiatry; 1999 Aug; 60(8):524-7. PubMed ID: 10485634
[TBL] [Abstract][Full Text] [Related]
26. [Withdrawal symptoms in connection with the use of selective serotonin reuptake inhibitors (SSRI)].
Gram LF
Ugeskr Laeger; 1998 Dec; 160(50):7291-3. PubMed ID: 9859737
[No Abstract] [Full Text] [Related]
27. [Olanzapine in the treatment of depressive disorders with psychotic symptoms].
Adli M; Rossius W; Bauer M
Nervenarzt; 1999 Jan; 70(1):68-71. PubMed ID: 10087520
[TBL] [Abstract][Full Text] [Related]
28. Olanzapine-induced weight gain in patients with first-episode schizophrenia: a double-blind, placebo-controlled study of fluoxetine addition.
Poyurovsky M; Pashinian A; Gil-Ad I; Maayan R; Schneidman M; Fuchs C; Weizman A
Am J Psychiatry; 2002 Jun; 159(6):1058-60. PubMed ID: 12042201
[TBL] [Abstract][Full Text] [Related]
29. Rabbit syndrome treated with olanzapine.
Durst R; Katz G; Zislin J; Raskin S; Kalman I
Br J Psychiatry; 2000 Feb; 176():193. PubMed ID: 10755060
[No Abstract] [Full Text] [Related]
30. Olanzapine for the treatment of tardive dyskinesia.
Almeida OP
J Clin Psychiatry; 1998 Jul; 59(7):380-1. PubMed ID: 9714267
[No Abstract] [Full Text] [Related]
31. Remission of chemotherapy-induced emesis with concurrent olanzapine treatment: a case report.
Pirl WF; Roth AJ
Psychooncology; 2000; 9(1):84-7. PubMed ID: 10668063
[No Abstract] [Full Text] [Related]
32. Remission of tardive dyskinesia after changing from flupenthixol to olanzapine.
Haberfellner EM
Eur Psychiatry; 2000 Aug; 15(5):338-9. PubMed ID: 10954879
[No Abstract] [Full Text] [Related]
33. Influence of fluoxetine on olanzapine pharmacokinetics.
Gossen D; de Suray JM; Vandenhende F; Onkelinx C; Gangji D
AAPS PharmSci; 2002; 4(2):E11. PubMed ID: 12102620
[TBL] [Abstract][Full Text] [Related]
34. Paroxetine discontinuation syndrome in association with sertindole therapy.
Walker-Kinnear M; McNaughton S
Br J Psychiatry; 1997 Apr; 170():389. PubMed ID: 9246265
[No Abstract] [Full Text] [Related]
35. Focus on olanzapine.
Green B
Curr Med Res Opin; 1999; 15(2):79-85. PubMed ID: 10494490
[TBL] [Abstract][Full Text] [Related]
36. Olanzapine: another psychotropic?
Davis MP; Dickerson ED
Am J Hosp Palliat Care; 2001; 18(2):129-32. PubMed ID: 11407129
[TBL] [Abstract][Full Text] [Related]
37. Misdiagnosis of schizophrenia for a patient with epilepsy.
Swartz CM
Psychiatr Serv; 2001 Jan; 52(1):109. PubMed ID: 11141543
[No Abstract] [Full Text] [Related]
38. Serotonin syndrome associated with clozapine withdrawal.
Stevenson E; Schembri F; Green DM; Burns JD
JAMA Neurol; 2013 Aug; 70(8):1054-5. PubMed ID: 23753931
[TBL] [Abstract][Full Text] [Related]
39. [Psychotic syndrome after withdrawal of cyproheptadine: remission with olanzapine].
De Lucas Taracena MT; Alcaina Prosper T; Huélamo Ortega MJ
Actas Esp Psiquiatr; 2000; 28(4):270-2. PubMed ID: 11116800
[TBL] [Abstract][Full Text] [Related]
40. Olanzapine augmentation of serotonin uptake inhibitors in obsessive-compulsive disorder: an open study.
Francobandiera G
Can J Psychiatry; 2001 May; 46(4):356-8. PubMed ID: 11387793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
